Figures computed from official regulatory filings — .
Analysttarget 8 USD (-19%) · consensus 2/5 · 0 buy · 1 hold · 2 sell
Ownershipinsiders 4.43% · institutions 73.78% · short 13.6% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Ginkgo Bioworks Holdings, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
4 buys777 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Coen Steven P. | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Shetty Reshma P. | Sell | $190.7K | SEC |
| Shetty Reshma P. | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Shetty Reshma P. | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Shetty Reshma P. | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Shetty Reshma P. | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Canton Barry | Sell | $190.7K | SEC |
| Shetty Reshma P. | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Shetty Reshma P. | Sell | $226.9K | SEC |
| Kelly Jason R | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Canton Barry | Sell | $226.9K | SEC |
| Canton Barry | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Shetty Reshma P. | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Shetty Reshma P. | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Canton Barry | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Kelly Jason R | Sell | $463.4K | SEC |
| Coen Steven P. | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Canton Barry | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Coen Steven P. | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Kelly Jason R | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Canton Barry | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kelly Jason R | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Canton Barry | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Kelly Jason R | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Canton Barry | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |